The omnipresent headlines about the deadly coronavirus underlines the importance of good, reliable healthcare in the modern world. For many other fundamental reasons it’s time for investors to take another look at the lagging U.S. healthcare sector. Thanks to a perspective drop in the sector’s equity risk premium (ERP), reduced federal regulatory risk and a potential sentiment reset, I upgrade the sector to an Overweight rating from Neutral (my stance since Dec. 2015). I’ll list 14 sector ideas for potential investment.
The past five years haven’t been kind to this sector, which has underperformed the Standard & Poor’s 500 index (SPX) by 1,710 basis points (+46% vs 63% for SPX). The combined headwinds of political backlash in Washington, D.C., extended valuations (for a time) and overly optimistic sentiment offset the sector’s fairly strong top-line and EPS growth.
You are trying to access member-only content. You are either lacking the required privileges or you are not logged in to view this content.
You need to have an active FSI Macro, or FSI Pro subcription in order to gain access to this article.If you are already a member at FS Insight, please Sign In. If you don’t have a subscription to FS Insight yet, please consider reading more about Our Services.